New York Life Investment Management »

Acumen Pharmaceuticals shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $385k 95k 4.05

More positions owned by New York Life Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Indexiq Etf Tr Candriam Us Larg (IQSU)
Amazon (AMZN)
Indexiq Active Etf Tr Iq Mackay Esg Cr (ESGB)
Indexiq Etf Tr Candriam Us Mid (IQSM)
Indexiq Etf Tr Iq 500 Int Etf (IQIN)
Indexiq Etf Tr Candriam Interna (IQSI)
Meta Platforms Cl A (META)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Indexiq Etf Tr Iq U.s. Small Ca (CSML)
Alphabet Cap Stk Cl A (GOOGL)
Indexiq Etf Tr Iq Cbre Nexgen (ROOF)
Indexiq Etf Tr Ftse Internl Eqt (HFXI)

View all positions for New York Life Investment Management

Top funds holding Acumen Pharmaceuticals

RA Capital Management
Sands Capital Ventures
Franklin Resources
Millennium Management
Rock Springs Capital Management
FMR
Laurion Capital Management
Vanguard Group
T. Rowe Price Associates
Alyeska Investment Group
Jane Street
Susquehanna International
Parkman Healthcare Partners
Hudson Bay Capital Management
Pathstone Holdings

View all funds holding Acumen Pharmaceuticals